STRS Ohio’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Buy
299,838
+289,682
+2,852% +$8.56M 0.04% 371
2026
Q1
$281K Buy
10,156
+817
+9% +$21K ﹤0.01% 1344
2025
Q4
$203K Buy
9,339
+17
+0.2% +$335 ﹤0.01% 1510
2025
Q3
$141K Buy
9,322
+267
+3% +$3.31K ﹤0.01% 1715
2025
Q2
$102K Buy
+9,055
New +$98.1K ﹤0.01% 1852
2023
Q4
Sell
-60,283
Closed -$704K 1998
2023
Q3
$704K Buy
+60,283
New +$682K ﹤0.01% 1043

Other funds holding ROIV

STRS Ohio's ROIV Position: Q2 2026 in Review

STRS Ohio increased its Roivant Sciences (ROIV) stake by 2,852% in Q2 2026, buying an estimated $8.56M and bringing the position to 299,838 shares worth $10.6M. The position accounts for 0.04% of the portfolio, ranked #371.

STRS Ohio first reported a position in ROIV in Q3 2023 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • STRS Ohio held 299,838 shares of Roivant Sciences worth $10.6M as of Q2 2026.
  • STRS Ohio bought 289,682 Roivant Sciences shares in Q2 2026, an estimated $8.56M.
  • Roivant Sciences made up 0.04% of STRS Ohio's portfolio in Q2 2026, its #371 holding.
  • STRS Ohio first reported a position in Roivant Sciences in Q3 2023 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.